Progenitor cells and retinal angiogenesis
- 13 March 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Angiogenesis
- Vol. 10 (2), 89-101
- https://doi.org/10.1007/s10456-007-9070-4
Abstract
Nothing more dramatically captures the imagination of the visually impaired patient or the ophthalmologist treating them than the possibility of rebuilding a damaged retina or vasculature with “stem cells.” Stem cells (SC) have been isolated from adult tissues and represent a pool of cells that may serve to facilitate rescue/repair of damaged tissue following injury or stress. We propose a new paradigm to “mature” otherwise immature neovasculature or, better yet, stabilize existing vasculature to hypoxic damage. This may be possible through the use of autologous bone marrow (BM) or cord blood derived hematopoietic SC that selectively target sites of neovascularization and gliosis where they provide vasculo- and neurotrophic effects. We have demonstrated that adult BM contains a population of endothelial and myeloid progenitor cells that can target activated astrocytes, a hallmark of many ocular diseases, and participate in normal developmental, or injury-induced, angiogenesis in the adult. Intravitreal injection of these cells from mice and humans can prevent retinal vascular degeneration ordinarily observed in mouse models of retinal degeneration; this vascular rescue correlates with functional neuronal rescue as well. The use of autologous adult BM derived SC grafts for the treatment of retinal vascular and degenerative diseases represents a novel conceptual approach that may make it possible to “mature” otherwise immature neovasculature, stabilize existing vasculature to hypoxic damage and/or rescue and protect retinal neurons from undergoing apoptosis. Such a therapeutic approach would obviate the need to employ destructive treatment modalities and would facilitate vascularization of ischemic and otherwise damaged retinal tissue.Keywords
This publication has 66 references indexed in Scilit:
- Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct sizeInternational Journal of Cardiology, 2007
- Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathyJCI Insight, 2006
- Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial functionAmerican Heart Journal, 2006
- Potential Role of Microglia in Retinal Blood Vessel FormationInvestigative Ophthalmology & Visual Science, 2006
- Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytesNature Medicine, 2006
- Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-upInternational Journal of Cardiology, 2006
- Derivation of Functional Endothelial Progenitor Cells from Human Umbilical Cord Blood Mononuclear Cells Isolated by a Novel Cell Filtration DeviceThe International Journal of Cell Cloning, 2004
- Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factorExperimental Eye Research, 2004
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003
- CD31 Expression in Intratumoral MacrophagesThe American Journal of Surgical Pathology, 2001